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C e ~ c a l  carcinoma is the second most common malignancy among 
women worldwide. The highest incidence rates are observed in 
developing countries. The susceptibility to cervical carcinoma in high 
incidence populations may result from several factors including human 
papillomavirus (HPV) exposure and both inherited and acquired genes. 
HPV infection does not always led to cervical cancer. In cervical 
carcinoma the other common genetic characteristic of cancer is the 
presence of several recurrent genetic alterations, not related to HPV. The 
type of recurrent genetic damage might take different forms such as  gene 
amplification, chromosomal translocation, deletions, loss of 
heterozygosity, point mutation, transcriptional silencing, and in some 
tumors viral DNA integration. 
To deter-mine the possible genetic alterations amongst the Malaysian 
women with cervical cancer, this study was conducted on 50 cervical 
tumor biopsies received from the Department of Obstetrics and 
Gynecology of the Hospital Kuala Lumpur. The objectives of the study 
were; i) the establishment of short-term primary cell culture of human 
cervical epithelial cells derived from cervical tumors for the 
determination of the prevalence and the type of chromosomal 
aberrations, ii) characterization of the allelic losses of the chromosomes 
3p, 5p, 11 and 17p (p53), subsequently identification of a possible site of 
candidate tumor suppressor gene(s) and iii) to determine the HPV status 
of the cervical cancers. Primary cell culture and cytogenetic techniques 
were performed on the cervical tumor biopsies. G-banding was employed 
for the identification of the chromosomes. To define the localization of 
the tumor suppressor genes, loss of heterozygosity study was performed 
on 37  cervical cancer cells. Twenty-four microsatellite polymorphic 
markers for the chromosomes 3p, 5p, 11 and p53 were chosen, the 
normal and tumor DNAs from each patient were analyzed for the allelic 
loss using PCR-based microsatellite analysis. The status for HPV 16 E6 
and HPV 18 E6 was detected by PCR method. 
Twenty-five cervical cancer biopsies were successfully karyotyped and 
near-diploid was the modal number, with a majority of them being 
hypodiploid (35-45). About 50% of the metaphases obtained in the 25 
tumors were hypodiploids, 12.1% were hyperdiploids, and 36.7% were 
diploids. Numerical abnormalities were predominantly observed in the 
patients, with monosomies of chromosomes 17, 22, X, 1 1, 18, 19, 13, 
and 6. Fluorescence in situ hybridization using centromeric 
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probes 1 1, 17 and 18 confirmed the presence of monosornies 1 1, 17, 18 
in a low percentage, 12.0%. 16.2% and 26.4% respectively. Several 
clones of cells were observed, with possibility of 45,)(X,-22; 45,XX.-11; 
45,=,- 19 and 45,XX.- 18. Twenty-six of the 36 informative individuals 
exhibited LOH at  one locus or more. The highest incidence was observed 
in chromosome 3p with the frequency of 48.6%. while a low frequency of 
2.7% was detected in the short-arm of chromosome 17 at position 
17~13.1,  whereby lies the p53 tumor suppressor. LOH was confined to 
four prominent regions, 1 1q23.3, 3p 14.2-3p 14.1, 3p2 1.32 and 3p25.3- 
3p25.1. No signiacant correlation was found between the LOH and the 
grade of cancer differentiation. The difference between the LOH 
frequency in cervical carcinomas with early stage and those with 
advanced stage was not statistically si@icant. Only 5 1.4% of the 35 
tumors were positive for HPV 16 E6 and 17.2% was HPV 18 E6 positive. 
HPV 16 was found to be positive in 64.7% of the Chinese, 41.7% in 
Malays and 50% in the Indians. Both the Malays and the Indians were 
observed to harbor the HPV 18 at a higher frequency (40 and 33.3% 
respectively) than the Chinese. In conclusion, besides HPV infection, 
other genetic abnormalities play a role in cervical carcinogenesis. LOH is 
a better method than chromosomal analysis in searching for possible 
tumor suppressor gene(s) that is responsible for c e ~ c a l  tumorigenesis. 
Mapping of the smallest region of LOH in these tumors and analysis of 
candidate genes present in the region of LOH will be continued. 
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Karsinoma s e ~ k s  adalah malignan kedua yang kerap berlaku di 
kalangan wanita di seluruh dunia. Insiden yang paling tinggi kerap 
dilihat di negara yang sedang membangun. Populasi yang mempunyai 
insiden tinggi mungkin mudah mendapat karsinoma serviks akibat 
pendedahan terhadap papilomavirus manusia (HPV) dan gen yang 
diwarisi atau diperolehi. Infeksi HPV bukan selalu menyebabkan kanser 
serviks. Bagi kanser serviks, ciri genetik yang kerap dilihat adalah 
beberapa pengubahan genetik yang berulang-ulang, yang tak berkaitan 
dengan HPV. Jenis kerosakan genetik yang berulang-ulang adalah 
seperti amplifikasi gen, translokasi kromosom, delesi, kehilangan 
heterozigositi, mutasi titik, transcriptional silencing dan integrasi virus. 
Kajian ini dijalan untuk mengetahui pengubahan gen di kalangan 
wanita yang mempunyai kanser serviks. 
Kajian ini melibatkan 50 biopsi barah serviks dari wanita yang 
menjalani rawatan barah senriks di Jabatan Obstetrik dan Ginekologi, 
Hospital Kuala Lumpur. Tujuan kajian ini adalah; i) membangunkan 
kultur sel primer daripada sel barah s e ~ k s  bagi menentukan prevalen 
dan jenis aberasi kromosom, ii) pencirian kehilangan alel (allelic loss) 
pada kromosom 3p, 5p, 11 dan 17p (p53), seterusnya pengenalpastian 
lokasi gen penumpas barah (tumor suppressor genes) dan iii) untuk 
menentukan status HPV dalam kanser s e ~ k s .  Kaedah kultur sel primer 
dan sitogenetik telah diperlakukan ke atas sampel biopsi barah s e ~ k s .  
Penjaluran-G telah digunakan untuk mengenalpasti kromosom. Untuk 
menentukan lokasi gen penumpas barah, kajian kehilangan 
heterozigositi telah dilakukan ke atas 37 sampel barah s e ~ k s .  Dua 
puluh empat penanda polimorfik mikrosatelit pada kromosom 3p, 5p, 11 
dan p53 telah dipilih. Pelet DNA normal dan barah dari setiap 37 sampel 
telah dianalisis menggunakan kaedah analisis mikrosatelit berasaskan 
PCR (PCR-based microsatellite analysis) untuk mengesan kehilangan 
alel. 
Dua puluh lima biopsi barah serviks telah berjaya dikariotip dan near- 
diploid telah dilihat sebagai modal number dengan majoriti adalah 
hipoploid (35-45). Lebih kurang 50% daripada taburan metafasa adalah 
hipoploid, 12.1% hiperploid dan 36.7% adalah diploid. Keabnormalan 
pada jumlah kromosom dilihat lebih utarna di kalangan pesakit, 
terutamanya monosomi kromosom 17, 22, X, 11, 18, 19, 13, dan 6. 
Penghibridan pendarfluor in situ ~uorescence in situ hybridization) 
menggunakan prob sentromerik bagi kromosom 1 1, 17 dan 18 telah 
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mengesahkan kehadiran monosomi kromosom tersebut tetapi pada 
kadar yang rendah, iaitu, 12.0%, 16.2% dn 26.4% masing-masing. 
Beberapa klon sel telah dijumpai, berkemungkinan 45,XX, -22; 45,XX, - 
11; 45,XX,-19 dan 45,XX,-18. Dua puluh enam daripada 36 individu 
yang informatif menunjukkan LOH pada satu lokus atau lebih. Insiden 
LOH yang tertinggi dikesan pada kromosom 3p dengan kekerapan pada 
kadar 48.6%, manakala LOH yang terendah adalah pada kekerapan 
2.7% yang dilihat pada kromosom 17p di posisi 17p 13.1. LOH telah 
dikesan pada empat kawasan yang utama, 1 1q23.3, 3p 14.2-3p 14.1, 
3p2 1.32 dan 3p25.3-3~25.1. Tiada korelasi yang signifikan ditemui di 
antara LOH dan gred pembezaan kanser. Perbezaan di antara kekerapan 
LOH dalam karsinoma s e ~ k s  di peringkat awal dan karsinoma di 
peringkat akhir adalah tidak signifikan. Hanya 5 1.4% daripada 35 barah 
serviks positif bagi HPV 16 E6 dan 17.2% positif untuk HPV 18 E6. HPV 
16 didapati positif di dalam 64.7% kaum Cina, 4 1.7% Melayu dan 50% 
di kalangan kaum India. Peratusan positif HPV 18 didapati lebih tinggi 
di kalangan kaum Melayu dan India berbanding kaum Cina. Sebagai 
rumusan, selain infeksi HPV, keabnormalan genetik juga berperanan 
dalarn proses karsinogenesis s e ~ k s .  LOH adalah kaedah yang lebih 
baik daripada kaedah analisis kromosom untuk mencari gen penumpas 
barah yang bertanggungjawab bagi proses barah s e ~ k s .  Kehadiran 
LOH dalarn barah s e ~ k s  mungkin boleh digunakan sebagai indikator 
terhadap prognosis penyakit tersebut. Pemetaan kawasan terkecil bagi 
LOH dalam barah ini serta analisis calon gen dalam kawasan LOH akan 
diteruskan. 
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